Carrie Melvin - 21 Jun 2022 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
COO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Carrie Melvin
Issuer symbol
VRDN
Transactions as of
21 Jun 2022
Net transactions value
$0
Form type
3
Filing time
24 Jun 2022, 17:23:16 UTC
Next filing
10 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRDN Stock Option (Right to Buy) 21 Jun 2022 Common Stock 210,000 $10.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on June 21, 2023 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney